Viral Hepatitis and Liver Cancer Control and Prevention Act of 2009

Issues relating to health disparities, health care reform, quality of life, federal health care programs, genetic information, cancer, nutrition, and wellness, including the following legislation: S. 494 and H.R. 912, Colorectal Cancer Prevention, Early Detection & treatment Act; H.R. 1213, Repeal mandatory funding provided to states in PPACA to establish American Health Benefit Exchanges; H.R. 1217, Repeal Prevention and Public Health Fund; H.R. 1740 and H.R. 5560, the Quality Cancer Care for Life Act of 2010; H.R. 2941 and S. 3493; HR 3974, Viral Hepatitis and Liver Cancer Control and Prevention Act of 2009; HR 4662, the Lymphedema Diagnosis and Treatment Cost Savings Act of 2010; the implementation of P.L. 111-148, the Patient Protection and Affordable Care Act of 2010; S. 1064, the Sun Act; S. 965, the Family Act; HR 2954, Health Equity and Accountability Act of 2011; and HR 2077, the MLR Repeal Act; H.R. 2245 and S. 296 Preserving Access to Life-Saving Medications Act, issues related to the reauthorization of the prescription drug user fee, and issues relating to the ongoing national shortage of cancer drugs.

Client expense: $360,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Issues relating to health disparities, health care reform, quality of life, federal health care programs, genetic information, cancer, nutrition, and wellness, including the following legislation: S 494 and HR 912, Colorectal Cancer Prevention, Early Detection & Treatment Act; HR 1213, Repeal mandatory funding provided to states in PPACA to establish American Health Benefit Exchanges; HR 1217, Repeal Prevention and Public Health Fund; HR 1740 and HR 5560, the Quality Cancer Care for Life Act of 2010; HR 2941 and S 3493; HR 3974, Viral Hepatatis and Liver Cancer Control and Prevention Act of 2009; HR 4662, the Lymphedema Diagnosis and Treatment Cost Savings Act of 2010; the implementation of P.L. 111-148, the Patient Protection and Affordable Care Act of 2010; S 1064, the Sun Act; S 965, the Family Act; HR 2954, Health Equity and Accountability Act of 2011; and HR 2077, the MLR Repeal Act.

Client expense: $240,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Issues relating to health disparities, health care reform, quality of life, federal health care programs, genetic information, cancer, nutrition, and wellness, including the following legislation: S. 494 and H.R. 912, Colorectal Cancer Prevention, Early Detection & Treatment Act; H.R. 1213, Repeal mandatory funding provided to states in PPACA to establish American Health Benefit Exchanges; H.R. 1217, Repeal Prevention and Public Health Fund; H.R. 1740 and H.R. 5560, the Quality Cancer Care for Life Act of 2010; HR 2941 and S 3493; HR 3974, Viral Hepatitis and Liver Cancer Control and Prevention Act of 2009; HR 4662, the Lymphedema Diagnosis and Treatment Cost Savings Act of 2010; the implementation of P.L. 111-148, the Patient Proection and Affordable Care Act of 2010; S. 1064, the Sun Act; S 965, the Family Act; HR2954, Health Equity and Accountability Act of 2011; and HR 2077, the MLR Repeal Act; H.R. 2245 and S. 296 Preserving Access to Life-Saving Medications Act, issues related to the reauthorization of the prescription drug user fee, and issues relating to the ongoing national shortage of cancer drugs.

Client expense: $1,030,000 · Firm income: Not reported

Government targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Labor, Dept of (DOL), Natl Institutes of Health (NIH), SENATE, State, Dept of (DOS), White House Office

Issues relating to health disparities, health care reform, quality of life, federal health care programs, genetic information, cancer, nutrition, and wellness, including the following legislation: S 494 and HR 912, Colorectal Cancer Prevention, Early Detection & Treatment Act; HR 1213, Repeal mandatory funding provided to states in PPACA to establish American Health Benefit Exchanges; HR 1217, Repeal Prevention and Public Health Fund; HR 1740 and HR 5560, the Quality Cancer Care for Life Act of 2010; HR 2941 and S 3493; HR 3974, Viral Hepatitis and Liver Cancer Control and Prevention Act of 2009; HR 4662, the Lymphedema Diagnosis and Treatment Cost Savings Act of 2010; the implementation of P.L. 111-148, the Patient Proection and Affordable Care Act of 2010; S. 1064, the Sun Act; S 965, the Family Act; HR2954, Health Equity and Accountability Act of 2011; and HR 2077, the MLR Repeal Act.

Client expense: $1,420,000 · Firm income: Not reported

Government targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Labor, Dept of (DOL), Natl Institutes of Health (NIH), SENATE, State, Dept of (DOS), White House Office

Issues related to health disparities, health care reform, quality of life, federal health care programs, genetic information, cancer, nutrition, and wellness, including the following legislation: H.R. 1189, Colorectal Cancer Prevention, Early Detection & Treatment Act; S. 494 and H.R. 912; H.R. 1213, repeal mandatory funding provided to states in PPACA to establish American Health Benefit Exchanges; H.R. 1217, Repeal Prevention & Public Health Fund; S. 488, the Access to Cancer Clinical Trials Act of 2009; H.R. 1740 and H.R. 5660, the Quality Cancer Care for Life Act of 2010; H.R. 2941 and S. 3493, Johanna's Law reauthorization; H.R. 3974, Viral Hepatitis and Liver Cancer Control and Prevention Act of 2009; H.R. 2366, the Cancer Drug Coverage Act of 2009; H.R. 4662, the Lymphedema Diagnosis and Treatment Cost Saving Act of 2010; the implementation of P.L. 111-148, the Patient Protection and Affordable Care Act of 2010; and child nutrition reauthorization bills(H.R. 5504, Improving Nutrition for America's Children Act, and S. 3307, Healthy, Hunger-Free Kids Act).

Client expense: $320,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Issues related to health disparities, health care reform, quality of life, federal health care programs, genetic information, cancer, nutrition, and wellness, including the following legislation: H.R.1189, Colorectal Cancer Prevention, Early Detection & Treatment Act; S.494, and H.R.912; H.R.1213, Repeal mandatory funding provided to states in PPACA to establish American Health Benefit Exchanges; H.R.1217, Repeal Prevention & Public Health Fund; S.488, the Access to Cancer Clinical Trials Act of 2009; H.R.1740 and H.R.5560, the Quality Cancer Care for Life Act of 2010; H.R.2941 and S.3493, H.R.3974, Viral Hepatitis and Liver Cancer Control and Prevention Act of 2009; H.R.2366, the Cancer Drug Coverage Act of 2009; H.R.4662, The Lymphedema Diagnosis and Treatment Cost Saving Act of 2010; the implementation of P.L.111-148, the Patient Protection and Affordable Care Act of 2010; S.1064, the Sun Act; S.965, the Family Act, and H.R.2077, the MLR Repeal Act.

Client expense: $540,000 · Firm income: Not reported

Government targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Labor, Dept of (DOL), Natl Institutes of Health (NIH), SENATE, State, Dept of (DOS), White House Office

Issues related to health disparities, health care reform, quality of life, federal health care programs, genetic information, cancer, nutrition, and wellness, including the following legislation: H.R. 1189, Colorectal Cancer Prevention, Early Detection & Treatment Act; S. 494 and H.R. 912; H.R. 1213, repeal mandatory funding provided to states in PPACA to establish American Health Benefit Exchanges; H.R. 1217, repeal Prevention & Public Health Fund; S. 488, the Access to Cancer Clinical Trials Act of 2009; H.R. 1740 and H.R. 5560, the Quality Cancer Care for Life Act of 2010; H.R. 2941 and S. 3493, Johanna's Law reauthorization; H.R. 3974, Viral Hepatitis and Liver Cancer Control and Prevention Act of 2009; H.R. 2366, the Cancer Drug Coverage Act of 2009; H.R. 4662, the Lymphedema Diagnosis and Treatment Cost Saving Act of 2010; the implemenatation of P.L. 111-148, the Patient Protection and Affordable Care Act of 2010; and child nutrition reauthorization bills (H.R. 5504, Improving Nutrition for America's Children Act, and S. 3307, Healthy, Hunger-Free Kids Act).

Client expense: $420,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

The Patient Protection and Affordable Care Act (HR 3590) - implementation support for Medicaid expansion, prevention and public health provisions, regulations on essential benefits, internal appeals and external review, prevention coverage, pre-existing condition insurance plans. National HIV/AIDS Strategy - support and implementation recommendations Viral Hepatitis and Liver Cancer Prevention and Control Act (HR 3974) - general support for legislation

Client expense: $5,157 · Firm income: Not reported

Government targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Management & Budget (OMB), Office of Natl AIDS Policy, SENATE, White House Office

The Patient Protection and Affordable Care Act (HR 3590) - implementation support for Medicaid expansion, prevention and public health provisions, regulations on essential benefits, internal appeals and external review, prevention coverage, pre-existing condition insurance plans. National HIV/AIDS Strategy - support and implementation recommendations Viral Hepatitis and Liver Cancer Prevention and Control Act (HR 3974) - general support for legislation Syring Exchange Program guidance - implementation of the provision Small Business Jobs and Credit Act (HR 5297) - oppose Johanns amendment to use Prevention and Public Health Fund as offset

Client expense: $13,107 · Firm income: Not reported

Government targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Management & Budget (OMB), Office of Natl AIDS Policy, SENATE, White House Office

Issues related to health disparities, health care reform, quality of life, federal health care programs, genetic information, cancer, nutrition, and wellness, including the following legislation; H.R. 1189, Colorectal Cancer Prevention, Early Detection & Treatment Act; S. 494 and H.R. 912; H.R. 1213, repeal mandatory funding provided to states in PPACA to establish American Health Benefit Exchanges; H.R. 1217, Repeal Prevention & Public Health Fund; S. 488, The Access to Cancer Clinical Trials Act of 2009; H.R. 1740 and H.R. 5560, the Quality Cancer Care for Life Act of 2010; H.R. 2941 and S. 3493, Johanna's Law reauthorization; H.R. 3974, Viral Hepatitis and Liver Cancer Control and Prevention Act of 2009; H.R. 2366, the Cancer Drug Coverage Act of 2009; H.R. 4662, The Lymphedema Diagnosis and Treatment Cost Saving Act of 2010; and child nutrition reauthorization bills (H.R. 5504, Improving Nutrition for America's Children Act, and S. 3307, Healthy, Hunger-Free Kids Act).

Client expense: $380,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

HR 1429: Stop AIDS in Prison Act of 2009 HR 1964 & S 3011: Black Clergy for the Elimination of HIV/AIDS HR 3974: Viral Hepatitis & Liver Cancer Control & Prevention Act of 2009 S 3711: Viral Hepatitis and Liver Cancer Control and Prevention Act of 2010 Hep Action Plan Reimbursement for Oral Test

Client expense: Not reported · Firm income: $10,000

Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, Veterans Affairs, Dept of (VA)

Issues related to health disparities, health care reform, quality of life, federal health care programs, genetic information, cancer, nutrition, and wellness, including the following legislation: H.R.1189, Colorectal Cancer Prevention, Early Detection & Treatment Act; S.494, and H.R.912; H.R.1213, Repeal mandatory funding provided to states in PPACA to establish American Health Benefit Exchanges; H.R.1217, Repeal Prevention & Public Health Fund; S.488, the Access to Cancer Clinical Trials Act of 2009; H.R.1740 and H.R.5560, the Quality Cancer Care for Life Act of 2010; H.R.2941 and S.3493, Johanna's Law reauthorization; H.R.3974, Viral Hepatitis and Liver Cancer Control and Prevention Act of 2009; H.R.2366, the Cancer Drug Coverage Act of 2009; H.R.4662, The Lymphedema Diagnosis and Treatment Cost Saving Act of 2010; the implementation of P.L.111-148, the Patient Protection and Affordable Care Act of 2010; and child nutrition reauthorization bills (H.R.5504, Improving Nutrition for America's Children Act, and S.3307, Healthy, Hunger-Free Kids Act).

Client expense: $750,000 · Firm income: Not reported

Government targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Labor, Dept of (DOL), SENATE, State, Dept of (DOS), White House Office

H.R. 1298, S. 525 & S. 1232, Pharmaceutical Market Access and Drug Safety Act - Lobbied against passage of legislation to allow for the importation of unsafe prescription drugs. H.R. 3081 and H.R. 4899 - Appropriations for AIDS Drug Assistance Program - Lobbied for increased access to HIV/AIDS drugs in the AIDS Drug Assistance Program. H.R. 3974, Viral Hepatitis and Liver Cancer Control and Prevention Act - Lobbied for passage of the bill to increase funding for education, awareness, and surveillance activities related to Viral Hepatitis. H.R. 1438, Promoting increased awareness and diagnosis of peripheral arterial disease (PAD) to address the high mortality rate of this treatable disease - Lobbied to educate members on peripheral arterial disease and for passage of bill. NO BILL, Health Care Reform Implementation - Lobbied on implementation of provisions in the health care reform bill regarding changes to the 340B drug pricing program, the Fee on pharmaceutical sales in government programs, the Independent Payment Advisory Board (IPAB), follow-on biologics, and the Patient-Centered Outcomes Research Institute (PCORI).

Client expense: $509,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, Health Resources & Services Administration (HRSA), SENATE, Treasury, Dept of

The Patient Protection and Affordable Care Act (HR 3590) - implementation support for Medicaid expansion, prevention and public health provisions, regulations on essential benefits, internal appeals and external review, prevention coverage, pre-existing condition insurance plans. National HIV/AIDS Strategy - support and implementation recommendations Viral Hepatitis and Liver Cancer Prevention and Control Act (HR 3974) - general support for legislation Syring Exchange Program guidance - implementation of the provision Small Business Jobs and Credit Act (HR 5297) - oppose Johanns amendment to use Prevention and Public Health Fund as offset

Client expense: $13,107 · Firm income: Not reported

Government targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Management & Budget (OMB), Office of Natl AIDS Policy, SENATE, White House Office

H.R. 1298, S. 525 & S. 1232, Pharmaceutical Market Access and Drug Safety Act - Lobbied against passage of legislation to allow for the importation of unsafe prescription drugs. H.R. 3081 and H.R. 4899 - Appropriations for AIDS Drug Assistance Program - Lobbied for increased access to HIV/AIDS drugs in the AIDS Drug Assistance Program. H.R. 3974, Viral Hepatitis and Liver Cancer Control and Prevention Act - Lobbied for passage of the bill to increase funding for education, awareness, and surveillance activities related to Viral Hepatitis. H.R. 1438, Promoting increased awareness and diagnosis of peripheral arterial disease (PAD) to address the high mortality rate of this treatable disease - Lobbied to educate members on peripheral arterial disease and for passage of bill. NO BILL, Health Care Reform Implementation - Lobbied on implementation of provisions in the health care reform bill regarding changes to the 340B drug pricing program, the Fee on pharmaceutical sales in government programs, the Independent Payment Advisory Board (IPAB), follow-on biologics, and the Patient-Centered Outcomes Research Institute (PCORI).

Client expense: $389,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, Health Resources & Services Administration (HRSA), SENATE, Treasury, Dept of

H.R. 1298, S. 525 & S. 1232, Pharmaceutical Market Access and Drug Safety Act - Lobbied against passage of legislation to allow for the importation of unsafe prescription drugs. H.R. 3081 and H.R. 4899 - Appropriations for AIDS Drug Assistance Program - Lobbied for increased access to HIV/AIDS drugs in the AIDS Drug Assistance Program. H.R. 3974, Viral Hepatitis and Liver Cancer Control and Prevention Act - Lobbied for passage of the bill to increase funding for education, awareness, and surveillance activities related to Viral Hepatitis. H.R. 1438, Promoting increased awareness and diagnosis of peripheral arterial disease (PAD) to address the high mortality rate of this treatable disease - Lobbied to educate members on peripheral arterial disease and for passage of bill. NO BILL, Health Care Reform Implementation - Lobbied on implementation of provisions in the health care reform bill regarding changes to the 340B drug pricing program, the Fee on pharmaceutical sales in government programs, the Independent Payment Advisory Board (IPAB), follow-on biologics, and the Patient-Centered Outcomes Research Institute (PCORI).

Client expense: $389,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, Health Resources & Services Administration (HRSA), SENATE, Treasury, Dept of

Implementation of Public Law 111-148, The Patient Protection and Affordable Care Act Implemenation of Public Law 111-152, The Reconciliation Act of 2010 S. 422 Heart Disease Education, Analysis Research, and Treatment for Women Act H.R. 5501, Henry J. Hyde U.S. Global Leadership Against HIV/AIDS, TB & Malaria Act H.R. 5440 - Genomics and Personalized Medicine Act of 2010 H.R. 3974: Viral Hepatitis and Liver Cancer Control and Prevention Act of 2009 S. 525 Pharmaceutical Market Access and Drug Safety Act of 2009 Policies for FDA product approval reform

Client expense: $1,750,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE

Issues related to health disparities, health care reform, quality of life, federal health care programs, genetic information, cancer, nutrition, and wellness, including the following legislation: H.R.1189, Colorectal Cancer Prevention, Early Detection & Treatment Act; S.717, and H.R.6224, The 21st Century Cancer Alert Act; proposed Senate national cancer program authorizing legislation; S.488, the Access to Cancer Clinical Trials Act of 2009; H.R.1740 and H.R.5560, the Quality Cancer Care for Life Act of 2010; H.R.2941 and S.3493, Johanna's Law reauthorization; H.R.3974, Viral Hepatitis and Liver Cancer Control and Prevention Act of 2009; H.R.2366, the Cancer Drug Coverage Act of 2009; H.R.4662, The Lymphedema Diagnosis and Treatment Cost Saving Act of 2010; the implementation of P.L.111-148, the Patient Protection and Affordable Care Act of 2010; and child nutrition reauthorization bills (H.R.5504, Improving Nutrition for America's Children Act, and S.3307, Healthy, Hunger-Free Kids Act).

Client expense: $670,000 · Firm income: Not reported

Government targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Labor, Dept of (DOL), SENATE, State, Dept of (DOS), White House Office

The Patient Protection and Affordable Care Act (HR 3590) - implementation support for Medicaid expansion, prevention and public health provisions, regulations on essential benefits, internal appeals and external review, prevention coverage, pre-existing condition insurance plans. National HIV/AIDS Strategy - support and implementation recommendations Viral Hepatitis and Liver Cancer Prevention and Control Act (HR 3974) - general support for legislation Syring Exchange Program guidance - implementation of the provision Small Business Jobs and Credit Act (HR 5297) - oppose Johanns amendment to use Prevention and Public Health Fund as offset

Client expense: $5,357 · Firm income: Not reported

Government targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Management & Budget (OMB), Office of Natl AIDS Policy, SENATE, White House Office

HR 1429: Stop AIDS in Prison Act of 2009 HR 1964 & S 3011: Black Clergy for the Elimination of HIV/AIDS HR 3974: Viral Hepatitis & Liver Cancer Control & Prevention Act of 2009 S 3711: Viral Hepatitis and Liver Cancer Control and Prevention Act of 2010 Hep Action Plan Reimbursement for Oral Test

Client expense: Not reported · Firm income: $10,000

Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, Veterans Affairs, Dept of (VA)

Legislation on public health preparedness and response related to pandemic influenza. Influenza Pandemic Preparedness federal, state and local levels. H.R. 3974, Viral Hepatitis and Liver Cancer Control and Prevention act of 2009 H.R. 3590 Patient Protection and Affordable Care Act-FTC issue Ryan White CARE Act reauthorization

Client expense: Not reported · Firm income: $50,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Budget and appropriations for disease and injury prevention, including obesity and related diseases; pandemic influenza and emerging infectious diseases; physical activity; public health bioterrorism preparedness; food safety, environmental health; women's and children's health; and community-based public health interventions. Implementation of the Patient Protection and Affordable Care Act (Public Law 111-148) 1.Clean Energy Jobs and American Power Act (S. 1733) 2.Clean, Low-Emission, Affordable, New Transportation Efficiency Act (S. 575) 3.Complete Streets Act of 2009 (S. 584/H.R. 1443) 4.Public Health Emergency Response Act of 2009 (S. 957/H.R. 2231) 5.Public Health Workforce Development Act of 2009 (S. 1143/H.R. 2620) 6.Livable Communities Act of 2009 (S. 1619) 7.Health Care and Education Reconciliation Act of 2010 (H.R. 4872) 8.Child Safety, Care, and Education Continuity Act of 2010 (S. 2898) 9.Preservation of Antibiotics for Medical Treatment Act of 2009 (S. 619/H.R. 1549) 10.Healthy, Hunger-Free Kids Act of 2010 (S. 3307) 11.Child Nutrition Promotion and School Lunch Protection Act of 2009 (H.R. 1324/S. 934) 12.Healthy Local Policies for Schools Act (S. 3126) 13.Healthy Families Act (H.R. 2460/S. 1152) 14.Strategies to Address Antimicrobial Resistance Act (H.R. 2400) 15.FDA Food Safety Modernization Act (S. 510) 16.Viral Hepatitis and Liver Cancer Control and Prevention Act of 2009 (H.R. 3974/S. 3711) 17.WMD Prevention and Preparedness Act of 2010 (H.R.5498) 18.Weapons of Mass Destruction Prevention and Preparedness Act of 2009 (S. 1649) 19.Small Business Jobs and Credit Act (H.R. 5297) 20.Joint resolution providing for congressional disapproval under chapter 8 of Title 5, U.S. Code, of the rule relating to status as a grandfathered health plan under the Patient Protection and Affordable Care Act (S.J. Res 39) 21.National Commission on Children and Disasters Reauthorization Act of 2010 (H.R. 5266) 22.Stationary Source Regulations Delay Act (S. 3072) 23.National Foundation on Fitness, Sports, and Nutrition Establishment Act (S.1275) 24.Healthy Kids from Day One Act (S. 3298)

Client expense: $25,166 · Firm income: Not reported

Government targets: Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Homeland Security, Dept of (DHS), Office of Management & Budget (OMB), SENATE, Transportation, Dept of (DOT)

**see addendum page ***, no specific bill, Raising Awareness of Hepatitis C ***, no specific bill, public health funding for Hepatitis, appropriations for the Department of Health and Human Services, screening PL 111-148 - The Patient Protection and Affordable Care Act, implementation H.R. 3090 - Health Equity and Accountability Act of 2009, hepatitis awareness and screening H.R. 3974 - Viral Hepatitis and Liver Cancer Control and Prevention Act of 2009 S. 3711 Viral Hepatitis and Liver Cancer Control and Prevention Act of 2010

Client expense: Not reported · Firm income: $60,000

Government targets: Centers For Disease Control & Prevention (CDC), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), SENATE

Issues related to raising awareness of Hepatitis C (no specific bills); HR 3293, H.R. 3288: FY 2010 Labor/HHS/Education Appropriations, provisions related to viral hepatitis funding; H.R.3974: Viral Hepatitis and Liver Cancer Control and Prevention Act of 2009; all provisions; S. 3711, Viral Hepatitis and Liver Cancer Control and Prevention Act of 2010, all provisions; FY 2011 Labor/HHS/Education Appropriations, provisions related to viral hepatitis funding.

Client expense: $140,000 · Firm income: Not reported

Government targets: Centers For Disease Control & Prevention (CDC), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), SENATE

HR3974 Viral Hepatitis and Liver Cancer Control and Prevention Act

Client expense: $10,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

H.R. 1298, S. 525 & S. 1232, Pharmaceutical Market Access and Drug Safety Act - Lobbied against passage of legislation to allow for the importation of unsafe prescription drugs. H.R. 3081 and H.R. 4899 - Appropriations for AIDS Drug Assistance Program - Lobbied for increased access to HIV/AIDS drugs in the AIDS Drug Assistance Program. H.R. 3974, Viral Hepatitis and Liver Cancer Control and Prevention Act - Lobbied for passage of the bill to increase funding for education, awareness, and surveillance activities related to Viral Hepatitis. H.R. 1438, Promoting increased awareness and diagnosis of peripheral arterial disease (PAD) to address the high mortality rate of this treatable disease - Lobbied to educate members on peripheral arterial disease and for passage of bill. NO BILL, Health Care Reform Implementation - Lobbied on implementation of provisions in the health care reform bill regarding changes to the 340B drug pricing program, the Fee on pharmaceutical sales in government programs, the Independent Payment Advisory Board (IPAB), follow-on biologics, and the Patient-Centered Outcomes Research Institute (PCORI).

Client expense: $384,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, Health Resources & Services Administration (HRSA), SENATE, Treasury, Dept of

Budget and appropriations for disease and injury prevention, including obesity and related diseases; pandenic influenza and emerging infectious diseases; physical activity; public health bioterrorism preparedness; food safety; environmental health; women's and children's health; and community-based public health interventions. Implementation of the Patient Protection and Affordable Care Act (Public Law 111-148) 1.Clean Energy Jobs and American Power Act (S. 1733) 2.Clean, Low-Emission, Affordable, New Transportation Efficiency Act (S. 575) 3.Complete Streets Act of 2009 (S. 584/H.R. 1443) 4.Public Health Emergency Response Act of 2009 (S. 957/H.R. 2231) 5.Public Health Workforce Development Act of 2009 (S. 1143/H.R. 2620) 6.Livable Communities Act of 2009 (S. 1619) 7.Health Care and Education Reconciliation Act of 2010 (H.R. 4872) 8.Child Safety, Care, and Education Continuity Act of 2010 (S. 2898) 9.Preservation of Antibiotics for Medical Treatment Act of 2009 (S. 619/H.R. 1549) 10.Healthy, Hunger-Free Kids Act of 2010 (S. 3307) 11.Child Nutrition Promotion and School Lunch Protection Act of 2009 (H.R. 1324/S. 934) 12.Healthy Local Policies for Schools Act (S. 3126) 13.Healthy Families Act (H.R. 2460/S. 1152) 14.Strategies to Address Antimicrobial Resistance Act (H.R. 2400) 15.FDA Food Safety Modernization Act (S. 510) 16.Viral Hepatitis and Liver Cancer Control and Prevention Act of 2009 (H.R. 3974/S. 3711) 17.WMD Prevention and Preparedness Act of 2010 (H.R.5498) 18.Weapons of Mass Destruction Prevention and Preparedness Act of 2009 (S. 1649) 19.Small Business Jobs and Credit Act (H.R. 5297) 20.Joint resolution providing for congressional disapproval under chapter 8 of Title 5, U.S. Code, of the rule relating to status as a grandfathered health plan under the Patient Protection and Affordable Care Act (S.J. Res 39) 21.National Commission on Children and Disasters Reauthorization Act of 2010 (H.R. 5266) 22.Stationary Source Regulations Delay Act (S. 3072) 23.National Foundation on Fitness, Sports, and Nutrition Establishment Act (S.1275) 24.Healthy Kids from Day One Act (S. 3298)

Client expense: $25,166 · Firm income: Not reported

Government targets: Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Homeland Security, Dept of (DHS), Office of Management & Budget (OMB), SENATE, Transportation, Dept of (DOT)

Budget and appropriations for disease and injury prevention, including obesity and related diseases; pandemic influenza and emerging infectious diseases; public health bioterrorism preparedness; environmental health; womens and childrens health; and community based public health interventions. Implementation of the Patient Protection and Affordable Care Act (Public Law 111-148) 1.Clean Energy Jobs and American Power Act (S. 1733) 2.Clean, Low-Emission, Affordable, New Transportation Efficiency Act (S. 575) 3.Complete Streets Act of 2009 (S. 584/H.R. 1443) 4.Public Health Emergency Response Act of 2009 (S. 957/H.R. 2231) 5.Public Health Workforce Development Act of 2009 (S. 1143/H.R. 2620) 6.Livable Communities Act of 2009 (S. 1619) 7.Health Care and Education Reconciliation Act of 2010 (H.R.4872) 8.Child Safety, Care, and Education Continuity Act of 2010 (S. 2898) 9.Preservation of Antibiotics for Medical Treatment Act of 2009 (S. 619/H.R. 1549) 10.Healthy, Hunger-Free Kids Act of 2010 (S. 3307) 11.Child Nutrition Promotion and School Lunch Protection Act of 2009 (H.R. 1324/S. 934) 12.Healthy Local Policies for Schools Act (S. 3126) 13.Healthy Families Act (H.R. 2460/S. 1152) 14.Strategies to Address Antimicrobial Resistance Act (H.R. 2400) 15.FDA Food Safety Modernization Act (S. 510) 16.Viral Hepatitis and Liver Cancer Control and Prevention Act of 2009 (H.R. 3974/S. 3711) 17.WMD Prevention and Preparedness Act of 2010 (H.R.5498) 18.Weapons of Mass Destruction Prevention and Preparedness Act of 2009 (S. 1649) 19.Small Business Jobs and Credit Act (H.R. 5297) 20.Joint resolution providing for congressional disapproval under chapter 8 of Title 5, U.S. Code, of the rule relating to status as a grandfathered health plan under the Patient Protection and Affordable Care Act (S.J. Res 39)

Client expense: $22,000 · Firm income: Not reported

Government targets: Executive Office of the President (EOP), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Homeland Security, Dept of (DHS), Labor, Dept of (DOL), Office of Management & Budget (OMB), SENATE, Transportation, Dept of (DOT)

H.R. 759 Food and Drug Administration Globalization Act of 2009 S. 882 Drug and Device Accountability Act of 2009 H.R. 1346 Medical Device Safety Act of 2009 S. 540 Medical Device Safety Act of 2009 H.R. 1508 Sunshine in Litigation Act of 2009 S.537 Sunshine in Litigation Act of 2009 S. 386 Fraud Enforcement and Recovery Act of 2009 S. 458 False Claims Act Clarification Act of 2009 H.R. 1298 Pharmaceutical Market Access and Drug Safety Act of 2009 S. 525 Pharmaceutical Market Access and Drug Safety Act of 2009 S. 1232 Pharmaceutical Market Access and Drug Safety Act of 2009 S. 301 Physician Payments Sunshine Act of 2009 H.R. 1166 E-fencing Enforcement Act of 2009 H.R. 1173 Organized Retail Crime Act of 2009 S. 470 Combating Organized Retail Crime Act of 2009 H.R. 1788 False Claims Act Correction Act of 2009 H.R. 2892 Department of Homeland Security Appropriations, 2010 - provisions pertaining to Importation. H.R. 3202 Water Protection and Reinvestment Act - provisions pertaining to pharmaceuticals in the environment S. 1504 Notice Pleading Restoration Act of 2009 S. 1679 Affordable Health Choices Act H.R. 3200 America's Affordable Health Choices Act of 2009 S. 1796 America's Affordable Health Choices Act of 2009 H.R. 3590 Patient Protection and Affordable Care Act America's Healthy Future Act of 2009 H.R. 3974 Viral Hepatitis and Liver Cancer Control and Prevention Act of 2009 H.R. 2596 No Child Left Unimmunized Against Influenza Act of 2009 S. 2964 Strengthening Program Integrity and Accountability in Health Care Act S. 3002 Dietary Supplement Safety Act of 2010 H.R. 4872 Health Care and Education Affordability Reconciliation Act H.R. 5516 Access to Appropriate Immunizations for Veterans Act of 2010 H.R. 5503 Securing Protections for the Injured from Limitations on Liability Act H.R. 4899 Supplemental Appropriations Act, 2010 - provisions pertaining to Bio-defense funding and the Ryan White CARE Act S. 3686 Fiscal Year 2011 Labor HHS Appropriations, all provisions pertaining to the Ryan White CARE Act as well as related House Fiscal Year 2011 Labor-HHS Appropriations Ryan White CARE Act provisions H.R. 5923 Patients Freedom to Choose Act, reimbursement of OTC drugs under Flexible and Health Savings accounts S. 3673 Patients Freedom to Choose Act, reimbursement of OTC drugs under Flexible and Health Savings accounts S. 3397 Secure and Responsible Drug Disposal Act, drug safety

Client expense: $1,600,000 · Firm income: Not reported

Government targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE

The Patient Protection and Affordable Care Act (HR 3590) - implementation support for Medicaid expansion, prevention and public health provisions, regulations on Internal Appeals and External Review and Group Health Plans and Health Issuers Relating to Coverage of Preventive Services National HIV/AIDS Strategy - support and implementation recommendations Viral Hepatitis and Liver Cancer Prevention and Control Act (HR 3974) - general support for legislation Syring Exchange Program guidance - implementation of the provision Small Business Jobs and Credit Act (HR 5297) - oppose Johanns amendment to use Prevention and Public Health Fund as offset

Client expense: $9,989 · Firm income: Not reported

Government targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Management & Budget (OMB), Office of Natl AIDS Policy, SENATE, White House Office

Issues related to raising awareness of Hepatitis C (no specific bills); H.R. 3293, H.R. 3288: FY 2010 Labor/HHS/Education Appropriations, provisions related to viral hepatitis funding; H.R. 3974: Viral Hepatitis and Liver Cancer Control and Prevention Act of 2009, all provisions; FY 2011 Labor/HHS/Education Appropriations, provisions related to viral hepatitis funding; S. 3711: Viral Hepatitis and Liver Cancer Control and Prevention Act of 2010, all provisions.

Client expense: $370,000 · Firm income: Not reported

Government targets: Centers For Disease Control & Prevention (CDC), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), SENATE

Rx drug importation into the U.S., other than by drug's manufacturer (no specific bill). Requiring safety and cost savings certification by HHS Sec'y in any Rx drug importation legislation (no specific bill). Implementation of comparative effectiveness provisions of health care reform bill (H.R. 3590). Awareness and treatment of viral hepatitis (S. Res. 531; H.R. 3974). Expansion of the 340B pricing program to include additional covered entities and inpatient prescription drug utilization. Implementation of the Independent Payment Advisory Board provisions of health care reform bill (H.R. 3590). Reauthorization of the Prescription Drug User Fee Act (no specific bill).

Client expense: $2,163,510 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Legislation on public health preparedness and response related to pandemic influenza. Influenza Pandemic Preparedness federal, state and local levels. H.R. 3974, Viral Hepatitis and Liver Cancer Control and Prevention act of 2009 H.R. 3590 Patient Protection and Affordable Care Act-FTC issue Ryan White CARE Act reauthorization

Client expense: Not reported · Firm income: $50,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Pandemic Preparedeness: Tamiflu; Advocate on legislative changes in the health care reform bill regarding biosimilars; Monitor changes to outpatient 340B presecription drug discount program, including related provisions included in HR 4213 - American Jobs and Closing Tax Loopholes Act; S. 3793, Job Creation and TAx Cuts Act; All healthcare and biotechnology legislation. Stockpiling of antiviral in preparation of a pandemic, HHS Appropriations bill H.R. 1548 - Pathway for Biosimilars Act FDA Approval and Enforcement Issues Cancer Research Issues S. 3686 FY 2011 Appropriations, HHS HCR issues concerning clinical trials Congressional oversight issues Implementation issues related to the Patient Protection and Affordable Care Act H.R. 1 - Pandemic influenza funding H.R. 1105 Omnibus Appropriations Act, Pandemic Funding Issues Food Safety Bill, H.R. 4872 Health Care and Education Reconciliation Act of 2010 H.R. 3974 Viral Hepatitis and LIver Cancer Control and Prevention Act of 2009 H.R. 3590 Patient Projection and Affordable Care Act-FTC issue Ryan White CARE Act reauthorization S. 726/HR 1427 - Promoting Innovation and Access to Life-Saving Medicine Act Educational meetings in Senate with candiate for Patient Centered Outcomes Research Institute Board (PCORI)

Client expense: $1,226,727 · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), Executive Office of the President (EOP), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Homeland Security, Dept of (DHS), Office of Personnel Management (OPM), SENATE, Veterans Affairs, Dept of (VA)

H.R. 1298, S. 525 & S. 1232, Pharmaceutical Market Access and Drug Safety Act - Lobbied against passage of legislation to allow for the importation of unsafe prescription drugs. H.R. 3081 and H.R. 4899 - Appropriations for AIDS Drug Assistance Program - Lobbied for increased access to HIV/AIDS drugs in the AIDS Drug Assistance Program. H.R. 3974, Viral Hepatitis and Liver Cancer Control and Prevention Act - Lobbied for passage of bill. H.R. 1438, Promoting increased awareness and diagnosis of peripheral arterial diease (PAD) to address the high mortality rate of this treatable disease - Lobbied for passage of bill. NO BILL, Health Care Reform Implementation - Lobbied on implementation of provisions in the health care reform bill regarding changes to the 340B drug pricing program and the Fee on pharmaceutical sales in government programs.

Client expense: $795,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, Health Resources & Services Administration (HRSA), SENATE, Treasury, Dept of

**see addendum page ***, no specific bill, Raising Awareness of Hepatitis C ***, no specific bill, public health funding for Hepatitis, appropriations for the Department of Health and Human Services, screening PL 111-148 - The Patient Protection and Affordable Care Act, implementation H.R. 3090 - Health Equity and Accountability Act of 2009, hepatitis awareness and screening H.R. 3974 - Viral Hepatitis and Liver Cancer Control and Prevention Act of 2009 S. 3711 Viral Hepatitis and Liver Cancer Control and Prevention Act of 2010

Client expense: Not reported · Firm income: $60,000

Government targets: Centers For Disease Control & Prevention (CDC), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), SENATE

HR 1429: Stop AIDS in Prison Act of 2009 HR 1964 & S 3011: Black Clergy for the Elimination of HIV/AIDS HR 3974: Viral Hepatitis & Liver Cancer Control & Prevention Act of 2009 S 3711: Viral Hepatitis and Liver Cancer Control and Prevention Act of 2010

Client expense: Not reported · Firm income: $10,000

Government targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, Veterans Affairs, Dept of (VA)

**see addendum page ***, no specific bill, Raising Awareness of Hepatitis C ***, no specific bill, public health funding for Hepatitis, appropriations for the Department of Health and Human Services, screening PL 111-148 - The Patient Protection and Affordable Care Act, implementation H.R. 3090 - Health Equity and Accountability Act of 2009, hepatitis awareness and screening H.R. 3974 - Viral Hepatitis and Liver Cancer Control and Prevention Act of 2009

Client expense: Not reported · Firm income: $60,000

Government targets: Agency for Healthcare Research & Quality (AHRQ), Centers For Disease Control & Prevention (CDC), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE

Domestic HIV Policy issues (H.R.1429 - Stop AIDS in Prison Act of 2009; H.R.3974 - Viral Hepatitis and Liver Cancer Control and Prevention Act of 2009; HIV Testing and Treatment; Federal Employees Health Benefits and Program Coverage for Routine HIV screening.); Health Care Reform (H.R.3590 - Patient Protection and Affordable Care Act; H.R.4872 - Health Care and Education Affordability Reconciliation Act); Hepatitis B Funding for Screening and Linkage to Care Programs. International HIV and Health issues; International Trade and Intellectual Property Rights issues

Client expense: $350,000 · Firm income: Not reported

Government targets: Commerce, Dept of (DOC), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, State, Dept of (DOS), U.S. Trade Representative (USTR), Veterans Affairs, Dept of (VA)

Rx drug importation into the U.S., other than by drug's manufacturer (no specific bill). Requiring safety and cost savings certification by HHS Sec'y in any Rx drug importation legislation (no specific bill). Implementation of comparative effectiveness provisions of health care reform bill (H.R. 3590). Awareness and treatment of viral hepatitis (S. Res. 531; H.R. 3974). Expansion of the 340B pricing program to include additional covered entities and inpatient prescription drug utilization.

Client expense: $944,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

H.R. 759 Food and Drug Administration Globalization Act of 2009 S. 882 Drug and Device Accountability Act of 2009 H.R. 1346 Medical Device Safety Act of 2009 S. 540 Medical Device Safety Act of 2009 H.R. 1508 Sunshine in Litigation Act of 2009 S.537 Sunshine in Litigation Act of 2009 S. 386 Fraud Enforcement and Recovery Act of 2009 S. 458 False Claims Act Clarification Act of 2009 H.R. 1298 Pharmaceutical Market Access and Drug Safety Act of 2009 S. 525 Pharmaceutical Market Access and Drug Safety Act of 2009 S. 1232 Pharmaceutical Market Access and Drug Safety Act of 2009 S. 301 Physician Payments Sunshine Act of 2009 H.R. 1166 E-fencing Enforcement Act of 2009 H.R. 1173 Organized Retail Crime Act of 2009 S. 470 Combating Organized Retail Crime Act of 2009 H.R. 1788 False Claims Act Correction Act of 2009 H.R. 2892 Department of Homeland Security Appropriations, 2010 - provisions pertaining to Importation. H.R. 3202 Water Protection and Reinvestment Act - provisions pertaining to pharmaceuticals in the environment S. 1504 Notice Pleading Restoration Act of 2009 S. 1679 Affordable Health Choices Act H.R. 3200 America's Affordable Health Choices Act of 2009 S. 1796 America's Affordable Health Choices Act of 2009 H.R. 3590 Patient Protection and Affordable Care Act America's Healthy Future Act of 2009 H.R. 3974 Viral Hepatitis and Liver Cancer Control and Prevention Act of 2009 H.R. 2596 No Child Left Unimmunized Against Influenza Act of 2009 S. 2964 Strengthening Program Integrity and Accountability in Health Care Act S. 3002 Dietary Supplement Safety Act of 2010 H.R. 4872 Health Care and Education Affordability Reconciliation Act H.R. 5516 Access to Appropriate Immunizations for Veterans Act of 2010 H.R. 5503 Securing Protections for the Injured from Limitations on Liability Act H.R. 4899 Supplemental Appropriations Act, 2010 - provisions pertaining to Bio-defense funding and the Ryan White CARE Act Fiscal Year 2011 Labor, Health and Human Services Appropriations - provisions pertaining to the Ryan White CARE Act

Client expense: $1,210,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Rx drug importation into the U.S., other than by drug's manufacturer (no specific bill). Requiring safety and cost savings certification by HHS Sec'y in any Rx drug importation legislation (no specific bill). Implementation of comparative effectiveness provisions of health care reform bill (H.R. 3590). Awareness and treatment of viral hepatitis (S. Res. 531; H.R. 3974). Expansion of the 340B pricing program to include additional covered entities and inpatient prescription drug utilization.

Client expense: $895,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Rx drug importation into the U.S., other than by drug's manufacturer (no specific bill). Requiring safety and cost savings certification by HHS Sec'y in any Rx drug importation legislation (no specific bill). Implementation of comparative effectiveness provisions of health care reform bill (H.R. 3590). Awareness and treatment of viral hepatitis (S. Res. 531; H.R. 3974). Expansion of the 340B pricing program to include additional covered entities and inpatient prescription drug utilization.

Client expense: $842,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Pandemic Preparedeness: Tamiflu; Advocate on legislative changes in the health care reform bill regarding biosimilars; Monitor changes to outpatient 340B presecription drug discount program, including related provisions included in HR 4213 - American Jobs and Closing Tax Loopholes Act, and ddraft Senate amendments to the legislation; Labor, Health and Human Services Appropriations bill; H.R. 1548 - Pathway for Biosimilars Act; Health care and biotechnology legislation, including H.R. 3490; Implementation of P.L. 111-148, "Patient Protection and Affordable Care Act" and P.L. 111-152, "Reconciliation Act of 2010", including comparative effectiveness provisions; S. 726/H.R. 1427 - Promoting Innovation and Access to Life-Saving Medicine Act; H.R. 1548 - Pathway for Biosimilars Act; Physician payment disclosure including S. 301; Physician Payments Sunshine Act of 2009; H.R. 3962, Affordable Health Care for Americans Act; H.R. 3590; Patient Protection and Affordable Care Act H.R. 4872, the Reconciliation Act of 2010; Follow on biologics includuing H.R. 154, the Pathway to Biosimilars Act; S. 726/H.R. 1427, Promoting Innovation and Access to Life Savings Medicines Act; H.R. 3962, Affordable health care for America Act; Comparative effectiveness legislation including S. 1213; Patient-Centered Outcomes Research Act of 2009; H.R. 3200, America's Health Future Act; H.R. 1548 - Pathway for Dissimilar Act; Legislative changes in the heatlh care reform bill regarding dissimilars; S. 1679 Affordeable Health Choice Act; S.1796, America's Health future Act of 2009; Pharmacuetical import safety legislation. H.R. 1105 Omnibus Appropriations Act of 2010; Supplemental Appropriations Act of 2010, Food Safety Issues concerning clinlical trials; H.R. 3974, Viral Hepatitis and Liver Cancer Control and Prevention Act of 2009 H.R. 3590 Patient Protetion and Affordable Care Act - FTC issue Ryan White CARE Act reauthorization

Client expense: $1,333,000 · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), Executive Office of the President (EOP), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Homeland Security, Dept of (DHS), Office of Personnel Management (OPM), SENATE, Veterans Affairs, Dept of (VA)

The Health Care and Education Reconciliation Act (HR 4872) - general support The Patient Protection and Affordable Care Act (HR 3590) - support for MEdicaid expansion, comprehensive sexual education, prevention and public health provisions, implementation Development of the National HIV/AIDS Strategy - general support for Strategy Viral Hepatitis and Liver Cancer Prevention and Control Act (HR 3974) - general support for legislation Syring Exchange Program guidance - implementation of the provision Addressing Cost Containment Measures to Ensure the Sustainability and Success of ADAP Act (ACCESS ADAP Act) (S 3401) - discussions regarding impact of legislation

Client expense: $11,328 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Management & Budget (OMB), Office of Natl AIDS Policy, SENATE, White House Office